Directory · CH
Biotechnology in Switzerland
A register of firms and the professionals working at them in the Biotechnology sector based in Switzerland. Browse the public index, then filter or export on Kipplo.
Companies
106 on file
Jungbunzlauer
Jungbunzlauer is a leading producer of high-quality, sustainable ingredients from natural sources, serving industries from food and beverage, to nutrition, health, home and personal care, among others. Leading the way in developing naturally better ingredients that enhance everyday life, we are a trusted partner offering a diverse portfolio of texturants, acidulants, sweeteners, minerals, and tailored solutions to meet our customers’ evolving needs. Headquartered in Basel, Switzerland, with state-of-the-art facilities including large-scale fermentation operations across Europe and North America, we proudly serve more than 130 countries worldwide. Founded more than 150 years ago, Jungbunzlauer has grown into a CHF 1.3 billion company, driven by nearly 1,400 dedicated colleagues committed to a healthier, more sustainable future. See our community guidelines here:
1001 to 5000 staff
Bnovate Technologies Sa
Safe Water. Anytime. Anywhere. bNovate Technologies SA develops robust and innovative instruments to set new standards in the field of rapid microbiological monitoring for pharmaceutical and drinking water. Thanks to our proprietary and fully automated industrial flow cytometry technology you don't need to wait 3 days to get your water microbiology results back, our instruments will do it in only 20 minutes!
11 to 50 staff
Swissdecode
SwissDeCode helps farmers and food manufacturers to grow and produce high quality products by offering a variety of rapid, on-site DNA testing solutions. We help brands launch new premium products faster and companies to transition to more sustainable value chain practices. Get in touch to discuss your testing needs.
11 to 50 staff
Fgen
FGen is an emerging Swiss company that combines biological engineering, such as synthetic biology, metabolic engineering, or non-GMO methods, with high throughput screening to design and optimize cells for biotechnological applications. Key to this process is FGen's proprietary nonoliter-reactor (NLR) platform that enables the phenotypic screening of cell libraries at rates of more than 1 million clones per day, thereby surpassing multi-well plate systems by orders of magnitude. The NLR technology enables analysis under relevant conditions (e.g. fed-batch cultivation, defined environments) and has successfully be used for production of small molecules and proteins by bacteria, yeast, fungi, and mammalian cells. FGen uses its expertise in biological engineering and high throughput screening in collaboration with industrial partners in industrial biotech, life sciences and pharma to develop products for various markets.
11 to 50 staff
Remp
Remp is part of Azenta Life Sciences. Researchers around the world are successfully accelerating breakthroughs to treat our most devastating diseases. We partner with scientists and clinicians all over the world to develop the sample management solutions that align with their workflows. It's these solutions that help researchers discover, test, and bring forth new medicines and therapies. Count on our global team of experts to customize solutions for samples at any stage in the lifespan — planning, collecting, transporting, processing, storing, analytics, retrieval, and disposal.
1001 to 5000 staff
Vitaris Ag
VITARIS beliefert Labors der Mikrobiologie und Zellkultur mit qualitativen Geräten sowie hochwertigem Verbrauchsmaterial. Der Bereich „Allgemeiner Laborbedarf“ bietet Produkte für vielfältige Lösungen für Anwender der Life Science Branche an und dank unserer eigenen Serviceabteilung sichern wir die Langlebigkeit Ihrer Anschaffungen. „A Difference in Life Science“ – dieses Versprechen soll uns als Leitschnur für unser Unternehmen dienen. Wenn sich alles gleicht, dann zählt der Unterschied. Wir möchten uns unterscheiden, mit einem freundlicheren Kundenservice, mit Kompetenz und mit einem Einsatz, der mehr als das Übliche ist. Alle unsere MitarbeiterInnen verfügen über langjähriges Know-how in ihrem Fachgebiet und dadurch über die entsprechende notwendige Kompetenz. Durch laufende Weiterbildung in Zusammenarbeit mit unseren Herstellern stellen wir sicher, dass wir kundengerechte Lösungen anbieten und Sie kompetent beraten können. Unsere Techniker werden in den Produktionsstätten unserer Lieferanten sorgfältig und regelmässig ausgebildet. Zudem verfügen sie über jahrelange Praxiserfahrung und garantieren Ihnen dadurch eine hohe Servicekompetenz.
11 to 50 staff
Engimmune Therapeutics
Engimmune is an immunotherapy company utilising cutting-edge methods for the development of T-cell receptor (TCR)-based immunotherapies including T cell therapies and biologics. By applying our unique protein engineering toolbox we have established and continue to develop proprietary high-throughput technology platforms enabling the discovery of highly potent and safe TCR-based cell therapies and biotherapeutics, thus covering the entire TCR discovery value chain. Operating as a platform technology and product development company, our vision is to become a globally leading provider of best-in-class TCR-based therapeutics for the treatment of serious human diseases with high unmet medical need, with a particular focus on oncology. Engimmune is based in a brand new science park in Allschwill, Basel in Switzerland
11 to 50 staff
Negotiumbio
At NegotiumBio, we support global pharma and biotech companies to develop and implement their outsourcing strategy across any drug modality. Our team is experienced in completing complex business transactions across a wide diversity of drug modalities including cellular and gene therapies (CAR-T, TCR, CRISPR, viral vector, autologous / allogenic supply chains, stem cell), biologics (mAB, protein, etc.), and small molecules. We help you to qualify, choose and manage your suppliers applying a systematic diligence process. This allows you to mitigate the risks commonly associated with outsourced manufacturing, regardless of your location. In addition, we provide guidance for developing raw material (GMP and non-GMP) management programs through either direct OEM or consolidation strategies enabled with the latest digital cataloging and/or marketplace cloud tools. RESEARCH: We scan the market to help you to make informed outsourcing decisions. MODELLING: We infer the costs to manufacture your product through our deep understanding of technical operations and the materials markets. RISK ASSESSMENT: We evaluate your supply chain holistically to identify both macro and micro risks. DUE DILIGENCE: We help you ensure a well-documented and thorough supplier qualification process to meet cGMP requirements. NEGOTIATE: We work with your scientists and development teams to better position them at the negotiation table MANAGE: We are happy to continue to manage the supplier relationship and support your subsequent project management needs. CONTACT US: NegotiumBio, LLC, North Andover, USA NegotiumBio GmbH, Basel, Switzerland inquiries@negotiumbio.com
1 to 10 staff
Anjarium Biosciences Ag
Anjarium Biosciences is a cell and gene therapy tools and technology company headquartered in Switzerland. Our mission is to enable researchers and manufacturers to accelerate the discovery and delivery cycle of new and evolving genetic medicines. Our technology enables our partners to meet biology’s greatest challenges with increasingly flexible and customizable DNA constructs in pursuit of better human health. We offer a range of products to support research, development, and commercialization of genetic medicines. Our enzymatic, cell-free platform enables Anjarium to offer pure, infinitely customizable, stable synthetic DNA constructs at scale for use across AAV, mRNA, Lentivirus and other applications.
11 to 50 staff
Athebio Ag
Athebio enables innovative drug developers to create superior targeted therapeutics of advanced efficacy and safety by providing them with tailor-made “plug and play” DARPins as building blocks, working together in a co-creative space, and supporting them with in-depth expertise.
11 to 50 staff
Atlantic Research Group
ARG is now part of Evestia Clinical. Follow Evestia Clinical's page to stay connected with our experienced team, our insights and opportunities in trial development. The new organization forms a leading mid-tier CRO with expanded global reach, enhanced therapeutic expertise, and a full-service clinical trial offering. ARG, founded in 2004, is a contract research organization focused on oncology, immunology, and neurology, providing comprehensive clinical program development services ranging from planning to commercialization, and achieving over 50 market authorizations to date. Built on the vision that every project should be highly individualized, ARG has experienced consistent global growth, expanding its range to include drug and device strategic consulting, clinical trial management services, and advanced clinical data and analytic solutions. ARG uses first-in-class technology platforms along with relationship-driven flexibility to optimize clinical studies, because we believe everyone deserves to be well.
51 to 200 staff
Ketoswiss Ag
KetoSwiss is a Swiss biotechnology company located in Basel, that develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolic dysfunction (such as Alzheimer's disease). The lead product’s active substance is an endogenous metabolite – a Ketone body, that can be used by the human brain as an alternative source of fuel to glucose, when glucose utilization or transport is compromised.
1 to 10 staff
Lubioscience
We are your go-to partner for life science reagents in Switzerland. More than 5 Million products from 130+ suppliers - whatever you are looking for, you'll find it at Lubio. With 20 years of experience in marketing & sales of Life Science reagents in Switzerland and Europe, we have a loyal customer base and an excellent relationship with our suppliers and brands. With our experienced and motivated team we aim to provide an efficient, reliable and professional service to our clients.
11 to 50 staff
Medlabdia
medlabdia is a specialized provider of laboratory, life science, and diagnostic solutions, helping laboratories scale intelligently through new equipment, validated pre-owned systems, consumables, and lifecycle support. We support laboratories, biotech companies, diagnostics organizations, research institutes, and industrial laboratories with high-quality laboratory infrastructure designed to improve operational flexibility, productivity, and long-term performance. Our offering includes: New laboratory equipment from selected innovative partners Professionally tested and certified pre-owned systems High-quality consumables and robotic tips Service, engineering expertise, and lifecycle support Unlike many transactional equipment suppliers, medlabdia combines equipment, consumables, and service support into a complete lifecycle approach that helps laboratories reduce operational risk while making smarter and more sustainable CAPEX decisions. With more than 20 years of experience, we support laboratory automation, liquid handling, molecular diagnostics, PCR/qPCR, protein purification, and analytical laboratory workflows, with strong expertise in Hamilton platforms. Through the collaboration with our service partner, we help laboratories improve uptime, continuity, and scalability across regional and global markets. Regional & global support Service-backed laboratory solutions 🧪 Consumables & robotic tips Validated pre-owned systems sales@medlabdia.com
11 to 50 staff
Saferworldbydesign
SaferWorldbyDesign engages a global consortium of dedicated innovators with the shared goal of advancing the science and technology necessary to protect the wellness and safety of consumers and the environment. Our part in this goal is to support the design of intelligent, effective, and safer products by providing integrated solutions to test and assess individual ingredients and formulations. Our solution-oriented platforms, solutions, and products integrate in silico and in vitro methods which support the design and testing of intelligent, safer products using new approach methods in toxicology and next-generation risk assessment. Our partners bring expertise in the best emerging research methods in toxicology, Artificial Intelligence, biology, chemistry, risk assessment, and computer science to provide a one-stop-shop for designing a safer world.
201 to 500 staff
Ymc Chromacon
YMC ChromaCon has a unique range of process and process control patents and together with our scale-up partner, YMC America, we offer chromatography solutions from laboratory to GMP process scale. Our vision is to improve the efficiency of bioprocessing by providing best-in-class chromatography equipment to develop and manufacture the next-generation of chemical and biological medicines using continuous manufacturing technology. Continuous manufacturing offers 30-50% reduction in CAPEX and OPEX compared to conventional batch manufacturing. We are unique in providing a twin-column FPLC development system, the Contichrom CUBE, for the continuous purification of peptides, oligonucleotides, mAbs, and small molecules. The Contichrom CUBE has multiple process capabilities allowing our customers to choose the best purification process for any given purification challenge. Chromatographic processes developed on the Contichrom CUBE can be scaled directly to any Contichrom TWIN, our line of GMP capable continuous manufacturing systems. ChromaCon AG was founded in 2008 and acquired by YMC in 2019. Within the YMC Group, YMC ChromaCon is the center of excellence for developing and commercializing continuous chromatographic process technologies. YMC ChromaCon is based in Switzerland but has a global footprint.
501 to 1000 staff
Agrosustain Sa
AgroSustain – a one-stop-shop solution for biological plant protection. We aim to reduce food waste and support organic food production by developing farm to fork solutions, like biological fungicides and coatings. AgroSustain has developed a pipeline of plant-derived antifungal compounds against broad range of agronomically important fungal pathogens present in pre-(in the field) and post-harvest (in storage). AgroSustain’s first product, called AgroShelf+, extends shelf life of vegetables & fruits infected with mostly spread molds. AgroSustain’s B2B customers, food distributors & producers with post-harvest storage facilities, that value more the effectiveness of the product on crops rather than the price. Post-harvest application of AgroShelf+ on stored perishable food can be done with spray, dipping or fogging in storage facilities or packing houses with no to minimal installation costs.
11 to 50 staff
Cellntec Advanced Cell Systems
CELLnTEC is a pioneering developer of chemically defined, animal and human components-free precision media. We enable stem cell research and cell therapy development, ultimately accelerating clinical application. CELLnTEC technology helps to unravel the mechanisms of human disease, ageing and longevity. Embracing precision medicine principles, CELLnTEC facilitates a growing range of regenerative medicine developments in skin, eye, airway, and other body parts, and emerging applications such as 3D bioprinting, lab-on-a-chip, cosmeceuticals, or biohybrid systems, limits to them yet to be imagined.
51 to 200 staff
Neovii
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.
51 to 200 staff
Immunos Therapeutics Ag
ImmunOs Therapeutics AG is developing the next generation of immunotherapies that have a role in the innate immune system for cancer and autoimmune diseases. The company is developing therapies that not only have direct anti-tumor effects but also remodel the tumor microenvironment to enhance the efficacy of existing immunotherapies. This portfolio of next generation, novel immunomodulatory proteins target diverse and key immunoregulatory receptors. Our lead program iosH2, now advancing to Phase 1 studies, is a multi-functional fusion protein that blocks specific LILRB (leukocyte immunoglobulin-like) receptors and thereby activates anti-tumor responses in multiple cancers with monotherapy and in combination with checkpoint inhibitors (CTLA-4, PD-1, PD-L1, CD47) and costimulatory agonists (e.g. 4-1BB).
11 to 50 staff
Lino Biotech Ag - A Miltenyi Biotec Company
Lino Biotech AG, a Miltenyi Biotec Company, advances drug discovery with its label-free focal molography platform, enabling real-time, multiplexed biomolecular interaction analysis in complex biological samples like human serum and living cells. By measuring interactions in their native environment, its MACS® Matchmaker system delivers precise kinetic and affinity data, especially for high-throughput DNA-encoded library (DEL) hit validation. From antibody screening to GPCR analysis, we provide high-sensitivity solutions that accelerate therapeutic development with unmatched biological relevance.
11 to 50 staff
Mabtree Biologics
mABTree Biologics is a biotech company based in Basel, Switzerland, focused on developing affordable, innovative monoclonal antibody therapies for hematological cancers, such as myeloproliferative neoplasms (MPNs), and autoimmune diseases. Founded in 2019, mABTree aims to make cutting-edge immunotherapies more accessible to patients worldwide. Our lead product, is a fully human antibody targeting a unique tumor marker and has shown promising preclinical results, including tumor reduction and depletion of mutant hematopoietic stem cells in MPN models. We are preparing for clinical trials and seeking partnerships and investments to accelerate development and potential regulatory approval by 2025, with a strategy for orphan drug status to expedite availability in underserved areas of oncology and hematology.
11 to 50 staff
Medxcell Sa
MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities.
11 to 50 staff
Novaremed Ag
Novaremed AG is a clinical-stage Swiss biopharmaceutical company, HQ in Basel, Switzerland, with a subsidiary in Israel. Novaremed is developing an orally active, first-in-class, small molecule (NRD.E1), with a novel mechanism of action, to treat Diabetic Neuropathic Pain.
1 to 10 staff
